MJP Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8M Buy
7,374
+210
+3% +$48.9K 0.22% 52
2025
Q4
$1.48M Buy
7,164
+935
+15% +$185K 0.19% 55
2025
Q3
$1.15M Buy
6,229
+641
+11% +$110K 0.15% 59
2025
Q2
$854K Sell
5,588
-406
-7% -$62.4K 0.13% 73
2025
Q1
$994K Buy
5,994
+543
+10% +$85K 0.18% 58
2024
Q4
$788K Sell
5,451
-1,570
-22% -$243K 0.14% 68
2024
Q3
$1.14M Buy
7,021
+730
+12% +$116K 0.22% 55
2024
Q2
$920K Sell
6,291
-1,660
-21% -$247K 0.19% 59
2024
Q1
$1.26M Buy
7,951
+2,752
+53% +$438K 0.27% 41
2023
Q4
$815K Sell
5,199
-762
-13% -$117K 0.22% 50
2023
Q3
$929K Sell
5,961
-2,429
-29% -$401K 0.27% 38
2023
Q2
$1.39M Sell
8,390
-535
-6% -$86.3K 0.45% 26
2023
Q1
$1.38M Buy
8,925
+59
+0.7% +$9.53K 0.42% 25
2022
Q4
$1.57M Buy
8,866
+473
+6% +$81.7K 0.46% 26
2022
Q3
$1.37M Buy
8,393
+134
+2% +$22.7K 0.41% 25
2022
Q2
$1.47M Buy
8,259
+955
+13% +$170K 0.41% 26
2022
Q1
$1.29M Buy
7,304
+1,049
+17% +$178K 0.33% 36
2021
Q4
$1.07M Buy
6,255
+262
+4% +$42.9K 0.32% 46
2021
Q3
$968K Sell
5,993
-938
-14% -$160K 0.33% 40
2021
Q2
$1.14M Buy
6,931
+232
+3% +$38.4K 0.38% 37
2021
Q1
$1.1M Sell
6,699
-79
-1% -$12.8K 0.45% 35
2020
Q4
$1.07M Buy
+6,778
New +$1M 0.45% 35

Other funds holding JNJ

MJP Associates's JNJ Position: Q1 2026 in Review

MJP Associates increased its Johnson & Johnson (JNJ) stake by 2.9% in Q1 2026, buying an estimated $48.9K and bringing the position to 7,374 shares worth $1.8M. The position accounts for 0.22% of the portfolio, ranked #52.

MJP Associates first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • MJP Associates held 7,374 shares of Johnson & Johnson worth $1.8M as of Q1 2026.
  • MJP Associates bought 210 Johnson & Johnson shares in Q1 2026, an estimated $48.9K.
  • Johnson & Johnson made up 0.22% of MJP Associates's portfolio in Q1 2026, its #52 holding.
  • MJP Associates first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.